L26/P-208 cIVF vs ICSI in non-severe male factor cycles: a sibling-oocyte split insemination strategy and fertilization success
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Siqueira und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What is the impact of sibling-oocyte split insemination strategy using conventional IVF and ICSI on fertilization outcomes in non-severe male factor cycles? Summary answer What is the impact of a sibling-oocyte split insemination strategy with cIVF and ICSI on fertilization outcomes in non-severe male factor cycles? What is known already ICSI is widely used beyond male-factor indications, despite ongoing debate regarding its added benefit over cIVF. ICSI-associated degeneration is frequently regarded as unavoidable, while fertilization failure after cIVF remains a clinically relevant problem often interpreted retrospectively. In the absence of cycle-specific evidence, insemination method selection in non-male factor is often empirical. Whether fertilization patterns justify the use of split insemination strategies has not been evaluated using sibling-oocyte analyses. Study design, size, duration Retrospective cohort study including 29,962 oocytes from 2,811 PGT-A cycles (2017–2025), in which sibling oocytes were inseminated by either cIVF or ICSI (40/60% cIVF/ICSI oocyte split). Outcomes were assessed on Day 1. Counterfactual whole-cycle and embryo-level analyses using Dirichlet–multinomial posterior prediction were performed to evaluate fertilization efficacy under alternative insemination strategies. Participants/materials, setting, methods Post-insemination outcomes were classified as 2PN, not fertilized, abnormal, or degenerate. Cycle-level fertilization rates were compared using within-cycle paired analyses. Counterfactual scenarios (‘only-cIVF’ and ‘only-ICSI’) were estimated while preserving each cycle’s oocyte yield. Cycles were stratified into three categories (low, intermediate and high) by observed ICSI degeneration and IVF fertilization failure rates to evaluate conditional insemination strategy effects; stratification cut-offs were derived from the cycle-level distribution (Q1 and Q3). Euploidy rates assessed in biopsied blastocysts. Main results and the role of chance ICSI outperformed cIVF in 45,1%, and cIVF outperformed ICSI in 42,4%, with tied outcomes in 12,5%. ICSI yielded slightly higher 2PN rates than cIVF (76.0% vs 74.0%; OR 1.11, 1.05–1.17, p < 001), but with higher degeneration. Total fertilization failure (TFF) occurred in only 0.9% of cycles. Counterfactual modelling predicted significantly higher TFF if all oocytes underwent cIVF (1.35%, p = 0.008) and borderline higher TFF under an only-ICSI strategy (1.19%, p = 0.056). Stratified analyses by ICSI degeneration demonstrated strong effect modification: in cycles with no degeneration, cIVF reduced 2PN rates (−9.7 pp) while increasing abnormal and failed fertilization, whereas in cycles with high degeneration (≥15.4%), cIVF increased 2PN (+13.4 pp) and reduced degeneration (−27.9 pp). When cycles were stratified by cIVF fertilization failure, counterfactual ICSI application reduced 2PN rates by -21.9 pp in low-fertilization failure cycles, had minimal effect in intermediate cycles, and increased 2PN by + 32.8 pp in high-failure cycles, with increased degeneration across all strata. Euploidy rates of the derived blastocysts were similar between cIVF and ICSI (cIVF 47.8% vc ICSI 48.0%; adjusted OR 0.98, p = 0.64). Limitations, reasons for caution Retrospective design, single-center setting and reliance on model-based estimation. Wider implications of the findings These findings suggest that split cIVF/ICSI insemination may improve cycle-level fertilization success and minimize total fertilization failure in non-severe male factor cycles, while supporting efficient use of laboratory resources without compromising euploidy safety. Trial registration number No
Zitieren
APA
Siqueira, S., Elkhatib, I., Didar, H., Bayram, A., Abdala, A., Ferracuti, V., Gonzales, R., Selim, S., Fatemi, H., & Nogueira, D. (2026). L26/P-208 cIVF vs ICSI in non-severe male factor cycles: a sibling-oocyte split insemination strategy and fertilization success. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.544
Vancouver
Siqueira S, Elkhatib I, Didar H, Bayram A, Abdala A, Ferracuti V, et al. L26/P-208 cIVF vs ICSI in non-severe male factor cycles: a sibling-oocyte split insemination strategy and fertilization success. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.544
BibTeX
@article{Siqueira2026,
author = {Siqueira, S. and Elkhatib, I. and Didar, H. and Bayram, A. and Abdala, A. and Ferracuti, V. and Gonzales, R. and Selim, S. and Fatemi, H. and Nogueira, D.},
title = {L26/P-208 cIVF vs ICSI in non-severe male factor cycles: a sibling-oocyte split insemination strategy and fertilization success},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.544}
}
EUVIMED